155 related articles for article (PubMed ID: 35575393)
1. Lactoferrin of oral fluid is normal and in Alzheimer's disease: laboratory and diagnostic aspects (review of literature).
Bazarnyi VV; Sidenkova AP; Sosnin DY
Klin Lab Diagn; 2022 Apr; 67(4):207-212. PubMed ID: 35575393
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population.
Gleerup HS; Jensen CS; Høgh P; Hasselbalch SG; Simonsen AH
EBioMedicine; 2021 May; 67():103361. PubMed ID: 33975253
[TBL] [Abstract][Full Text] [Related]
3. Salivary Biomarkers for Alzheimer's Disease: A Systematic Review with Meta-Analysis.
Nijakowski K; Owecki W; Jankowski J; Surdacka A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256241
[TBL] [Abstract][Full Text] [Related]
4. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
[TBL] [Abstract][Full Text] [Related]
5. Decreased salivary lactoferrin levels are specific to Alzheimer's disease.
González-Sánchez M; Bartolome F; Antequera D; Puertas-Martín V; González P; Gómez-Grande A; Llamas-Velasco S; Herrero-San Martín A; Pérez-Martínez D; Villarejo-Galende A; Atienza M; Palomar-Bonet M; Cantero JL; Perry G; Orive G; Ibañez B; Bueno H; Fuster V; Carro E
EBioMedicine; 2020 Jul; 57():102834. PubMed ID: 32586758
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.
Marksteiner J; Hinterhuber H; Humpel C
Drugs Today (Barc); 2007 Jun; 43(6):423-31. PubMed ID: 17612711
[TBL] [Abstract][Full Text] [Related]
8. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
Vanderstichele H; Bibl M; Engelborghs S; Le Bastard N; Lewczuk P; Molinuevo JL; Parnetti L; Perret-Liaudet A; Shaw LM; Teunissen C; Wouters D; Blennow K
Alzheimers Dement; 2012 Jan; 8(1):65-73. PubMed ID: 22047631
[TBL] [Abstract][Full Text] [Related]
9. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments.
Zetterberg H
Curr Opin Psychiatry; 2015 Sep; 28(5):402-9. PubMed ID: 26147615
[TBL] [Abstract][Full Text] [Related]
11. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
Molinuevo JL; Blennow K; Dubois B; Engelborghs S; Lewczuk P; Perret-Liaudet A; Teunissen CE; Parnetti L
Alzheimers Dement; 2014 Nov; 10(6):808-17. PubMed ID: 25150736
[TBL] [Abstract][Full Text] [Related]
12. ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration.
Cousins KAQ; Irwin DJ; Wolk DA; Lee EB; Shaw LMJ; Trojanowski JQ; Da Re F; Gibbons GS; Grossman M; Phillips JS
Brain; 2020 Jul; 143(7):2295-2311. PubMed ID: 32666090
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid in the dementias.
Zetterberg H; Rohrer JD; Schott JM
Handb Clin Neurol; 2017; 146():85-97. PubMed ID: 29110781
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.
Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P
J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers.
Lee JC; Kim SJ; Hong S; Kim Y
Exp Mol Med; 2019 May; 51(5):1-10. PubMed ID: 31073121
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.
Rivero-Santana A; Ferreira D; Perestelo-Pérez L; Westman E; Wahlund LO; Sarría A; Serrano-Aguilar P
J Alzheimers Dis; 2017; 55(2):625-644. PubMed ID: 27716663
[TBL] [Abstract][Full Text] [Related]
18. Low levels of salivary lactoferrin may affect oral dysbiosis and contribute to Alzheimer's disease: A hypothesis.
Olsen I; Singhrao SK
Med Hypotheses; 2021 Jan; 146():110393. PubMed ID: 33229194
[TBL] [Abstract][Full Text] [Related]
19. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.
Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H
BMC Neurol; 2009 Dec; 9():63. PubMed ID: 20028512
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
Toledo JB; Zetterberg H; van Harten AC; Glodzik L; Martinez-Lage P; Bocchio-Chiavetto L; Rami L; Hansson O; Sperling R; Engelborghs S; Osorio RS; Vanderstichele H; Vandijck M; Hampel H; Teipl S; Moghekar A; Albert M; Hu WT; Monge Argilés JA; Gorostidi A; Teunissen CE; De Deyn PP; Hyman BT; Molinuevo JL; Frisoni GB; Linazasoro G; de Leon MJ; van der Flier WM; Scheltens P; Blennow K; Shaw LM; Trojanowski JQ;
Brain; 2015 Sep; 138(Pt 9):2701-15. PubMed ID: 26220940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
